| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/08/2011 | EP2328861A2 Polymorphs of rasagiline hydrochloride |
| 06/08/2011 | EP2328858A1 Hydroxybutyrate ester and medical use thereof |
| 06/08/2011 | EP2328656A1 Therapeutic regimen comprising peg- interferon, ribavirin and vx-950 for the treatment of hepatitis " |
| 06/08/2011 | EP2328595A1 Methods for stimulating chondrogenesis utilizing a potassium channel inhibitor |
| 06/08/2011 | EP2328593A2 Cardioplegic preparation |
| 06/08/2011 | EP2328591A1 Formulations of canfosfamide and their preparation |
| 06/08/2011 | EP2328590A1 Topical hydrogel composition |
| 06/08/2011 | EP2328589A1 Treatment of vaginal atrophy in women with tumor pathology risk |
| 06/08/2011 | EP2328588A1 Treatment of anxiety disorders |
| 06/08/2011 | EP2328587A1 Dosage form comprising 1-isopropyl-4-{ [4-(tetrahydro-2h-pyran- 4-yloxy)phenyl]carbonyl}hexahydro-1h-1,4-diazepine or a salt thereof |
| 06/08/2011 | EP2328586A2 Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands |
| 06/08/2011 | EP2328585A1 Treatment of neonate foals with meloxicam |
| 06/08/2011 | EP2328584A2 Treatment of neurological disorders using huperzine |
| 06/08/2011 | EP2328583A1 New therapeutic use of drotaverine |
| 06/08/2011 | EP2328582A1 Transdermal extended-delivery donepezil compositions and methods for using the same |
| 06/08/2011 | EP2328581A1 Use of dabigatranetexilate for treating patients with pulmonary hypertension |
| 06/08/2011 | EP2328580A1 Dabigatran for percutaneous interventional cardiac catheterisation |
| 06/08/2011 | EP2328579A1 Trioxane dimer sulfur compounds |
| 06/08/2011 | EP2328578A2 Noscapine and noscapine analogs and their use in treating infectious diseases by tubulin binding inhibition |
| 06/08/2011 | EP2328577A1 The treatment of hearing loss |
| 06/08/2011 | EP2328576A1 Use of nmda activity enhancers to treat hypersomnia, reduced wakefulness or reduced vigilance |
| 06/08/2011 | EP2328575A1 A novel standardized composition, method of manufacture and use in the resolution of rna virus infection |
| 06/08/2011 | EP2328574A1 Treatment of retinal degeneration |
| 06/08/2011 | EP2328573A1 Antibacterial combination therapy for the treatment of gram positive bacterial infections |
| 06/08/2011 | EP2328572A1 Pkc-activating compounds for the treatment of neurodegenerative diseases |
| 06/08/2011 | EP2328571A1 Amino alcohol derivatives for the treatment of demyelinating peripheral neuropathies |
| 06/08/2011 | EP2328570A2 Method and formulation for treating adverse biological conditions |
| 06/08/2011 | EP2328569A1 Compositions and methods of treatment comprising ceftaroline |
| 06/08/2011 | EP2328568A1 Chewable formulation comprising alginate, bicarbonate and carbonate |
| 06/08/2011 | EP2328565A1 An extended release pharmaceutical composition of entacapone or salts thereof |
| 06/08/2011 | EP2328563A1 Solubility enhancing pharmaceutical formulation |
| 06/08/2011 | EP2328562A1 Galenical formulation comprising aliskiren and process for its preparation by melt extrusion granulation |
| 06/08/2011 | EP2328561A2 Rate modulated delivery of drugs from a composite delivery system |
| 06/08/2011 | EP2328558A2 Use of sucralose as a granulating agent |
| 06/08/2011 | EP2328557A1 Oral formulations of chemotherapeutic agents |
| 06/08/2011 | EP2328555A2 Compositions for the treatment of neoplastic diseases |
| 06/08/2011 | EP2328553A1 Corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
| 06/08/2011 | EP2328417A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF beta-AMYLOID DISEASES AND SYNUCLEINOPATHIES |
| 06/08/2011 | EP2328414A1 Substituted triazolo-pyridazine derivatives |
| 06/08/2011 | EP2328412A1 Iap inhibitors |
| 06/08/2011 | EP2328411A1 Pharmaceutical composition of a radioiodinated benzamide derivative and methods of making the same |
| 06/08/2011 | EP2207770B1 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors |
| 06/08/2011 | EP2188290B1 Pyrazolo[3,4-d]-pyramidine derivatives as antiproliferative agents |
| 06/08/2011 | EP2125714B1 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide |
| 06/08/2011 | EP2099462B1 Pharmaceutical preparation for the treatment of inflammatory diseases of the urogenital tract |
| 06/08/2011 | EP2064185B1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 06/08/2011 | EP2044054B1 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity |
| 06/08/2011 | EP2040691B1 Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl]benzoic acid |
| 06/08/2011 | EP1948664B1 Pyrrolotriazine kinase inhibitors |
| 06/08/2011 | EP1945648B1 Derivatives of 4,6-disubstituted 1,2,4-triazolo-1,3,4-thiadiazole, a process and uses thereof |
| 06/08/2011 | EP1940383B1 Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof |
| 06/08/2011 | EP1937264B1 Combination therapy for the treatment of urinary frequency, urinary urgency and urinary incontinence |
| 06/08/2011 | EP1912983B1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 06/08/2011 | EP1898900B1 Antimicrobial compositions comprising esters of hydroxycarboxylic acids |
| 06/08/2011 | EP1890683B1 Methods of supressing uv light-induced skin carcinogenesis |
| 06/08/2011 | EP1879895B1 Enzyme inhibitors |
| 06/08/2011 | EP1874777B1 1h-pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use |
| 06/08/2011 | EP1871368B1 Dihydropyridine compounds for neurodegenerative diseases and dementia |
| 06/08/2011 | EP1865935B1 Bisphosphonates for treating endometriosis |
| 06/08/2011 | EP1856043B1 1-h-pyrrole-2-carboxamides and imidazole-5-carboxamides and use thereof as fak, kdr and tie2 kinase modulators for the treatment of cancer |
| 06/08/2011 | EP1817312B1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/08/2011 | EP1812426B1 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 06/08/2011 | EP1809628B1 Phenylurea derivatives used as inhibitors of tyrosinkinase for treating tumors |
| 06/08/2011 | EP1766013B1 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases |
| 06/08/2011 | EP1757610B1 Condensed pyrimidine derivative and xanthine oxidase inhibitor |
| 06/08/2011 | EP1732548B1 Methods of using sustained release aminopyridine compositions |
| 06/08/2011 | EP1670801B1 Pyrazolo and imidazo-pyrimidine derivatives |
| 06/08/2011 | EP1573022B1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 06/08/2011 | EP1531800B1 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) |
| 06/08/2011 | EP1485127B1 Administration of agents for the treatment of inflammation |
| 06/08/2011 | EP1479397B1 2,4,6-triamino-1,3,5-triazine derivative |
| 06/08/2011 | EP1434579B1 Imidazole derivatives as antiinflammatory agents |
| 06/08/2011 | EP1431293B1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 06/08/2011 | EP1427427B1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 06/08/2011 | EP1392255B1 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof |
| 06/08/2011 | EP1320356B2 Preparation of vitamin emulsions and concentrates thereof |
| 06/08/2011 | EP1300407B2 Carbamates derived from arylalkylamines |
| 06/08/2011 | EP1296665B1 Analgesic and anti-inflammatory compositions containing celecoxib and ibuprofen |
| 06/08/2011 | EP1259259B1 Mucosal adjuvant formulation |
| 06/08/2011 | CN1989966B Pharmaceutical composition comprising rifamoin and isoniazid |
| 06/08/2011 | CN1930155B Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics |
| 06/08/2011 | CN1927877B siRNA for inhibiting human Ezrin gene expression and expression vector thereof |
| 06/08/2011 | CN1919241B Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease |
| 06/08/2011 | CN1914153B Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides and use as renin inhibitors |
| 06/08/2011 | CN1901914B Pharmaceutical composition of chloroquine and protease inhibitors, and its uses |
| 06/08/2011 | CN1895322B Jinganmin effervescent tablets and preparation thereof |
| 06/08/2011 | CN1890224B 6-substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose)polymerase inhibitors |
| 06/08/2011 | CN1889964B Enteropathy ameliorating composition |
| 06/08/2011 | CN1882524B 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 06/08/2011 | CN1882321B Pellets containing venlafaxine hydrochloride |
| 06/08/2011 | CN1871215B Cyclic derivatives as modulators of chemokine receptor activity |
| 06/08/2011 | CN1867564B Process for preparing amino crotonyl compounds |
| 06/08/2011 | CN1852722B Use of insulin and myristoylation PKC alpha Pseudo substrate in preparing medicine for healing skin wound |
| 06/08/2011 | CN1829703B (Thio)carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists |
| 06/08/2011 | CN1823838B Medicine and food dual purpose vitamin micro element mineral calcium nutritive product for preventing myopia and its manufacturing method |
| 06/08/2011 | CN1823837B Use of composition in preparing nutritire product for preventing and treating myopia |
| 06/08/2011 | CN1816544B Immunosuppressant compounds and compositions |
| 06/08/2011 | CN1777432B Anti-viral nucleoside analogs for treating HIV infections |
| 06/08/2011 | CN1771978B Notoginseng triol-saponin composition and its preparation and use |
| 06/08/2011 | CN1700918B N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |